[{"notes_id":"1_2588","category":"10","subcategory":"2","title":"Lower urinary tract symptoms in men","body":"Lower urinary tract symptoms (LUTS) in men are very common and are present in the majority of men aged > 50 years. They are most commonly secondary to benign prostatic hyperplasia but other causes should be considered including prostate cancer.<br \/><br \/>It is useful to classify the symptoms into 3 broad groups.<br \/><br \/><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Voiding<\/th><th>Storage<\/th><th>Post-micturition<\/th><\/tr><\/thead><tbody><tr><td>Hesitancy<br \/>Poor or intermittent stream<br \/>Straining<br \/>Incomplete emptying<br \/>Terminal dribbling<\/td><td>Urgency<br \/>Frequency<br \/>Nocturia<br \/>Urinary incontinence<\/td><td>Post-micturition dribbling<br \/>Sensation of incomplete emptying<\/td><\/tr><\/tbody><\/table><\/div> <br \/><br \/>Examination<br \/><ul><li>urinalysis: exclude infection, check for haematuria<\/li><li>digital rectal examination: size and consistency of prostate<\/li><li>a PSA test may be indicated, but the patient should be properly counselled first<\/li><\/ul><br \/>It is useful to get the patient to complete the following to guide management:<br \/><ul><li>urinary frequency-volume chart: distinguish between urinary frequency, polyuria, nocturia, and nocturnal polyuria.<\/li><li>International Prostate Symptom Score (IPSS): assess the impact on the patient's life. This classifies the symptoms as mild, moderate or severe<\/li><\/ul><br \/><h5 class='notes-heading'>Management<\/h5><br \/>Predominately voiding symptoms<br \/><ul><li>conservative measures include: pelvic floor muscle training, bladder training, prudent fluid intake and containment products <\/li><li>if 'moderate' or 'severe' symptoms offer an alpha-blocker<\/li><li>if the prostate is enlarged and the patient is 'considered at high risk of progression' then a 5-alpha reductase inhibitor should be offered<\/li><li>if the patient has an enlarged prostate and 'moderate' or 'severe' symptoms offer both an alpha-blocker and 5-alpha reductase inhibitor<\/li><li>if there are mixed symptoms of voiding and storage not responding to an alpha blocker then a antimuscarinic (anticholinergic) drug may be added<\/li><\/ul><br \/>Predominately overactive bladder<br \/><ul><li>conservative measures include moderating fluid intake<\/li><li>bladder retraining should be offered<\/li><li>antimuscarinic drugs should be offered if symptoms persist. NICE recommend oxybutynin (immediate release), tolterodine (immediate release), or darifenacin (once daily preparation)<\/li><li>mirabegron may be considered if first-line drugs fail<\/li><\/ul><br \/>Nocturia<br \/><ul><li>advise about moderating fluid intake at night<\/li><li>furosemide 40mg in late afternoon may be considered<\/li><li>desmopressin may also be helpful<\/li><\/ul>","notes_hash":"933edd77cbb77381eb486f9af0ef1512","knowledge_graph_node_id_link":0,"links":"","media":"","concepts_for_notes":[],"category_name":"Renal \/ Urology","subcategory_name":"Urology","comment_count":4},"",[]]